#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16020	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2147	742.2	0	.	n	.	0	C207T	SNP	207	207	C	522	522	T	936	T,C,G	601,249,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16020	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2147	742.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1499	1499	C	906	C	847	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	0	.	n	.	0	T695C	SNP	695	695	T	1068	1068	C	915	C	849	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	913	C,T,A	845,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	950	A	896	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	933	C,T	869,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	0	HET	.	.	.	A1638G	.	1638	1638	A	2011	2011	A	986	A,G	499,425	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30098	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3516	852.4	0	HET	.	.	.	A423G	.	423	423	A	796	796	A	947	A,G	651,223	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1824	folP	855	855	100.0	folP.l15.c4.ctg.1	1490	122.0	1	SNP	p	R229S	1	.	.	685	687	AGC	963	965	AGC	181;181;180	A;G;C	171;172;169	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5608	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	167.7	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	190;190;192	T;T;C	173;173;172	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5608	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	167.7	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	188;190;190	G;G;C,T	175;173;169,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5608	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3329	167.7	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	188;190;190	G;G;C,T	175;173;169,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1588	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1340	118.0	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	192;194;196	G;G;C,T	177;182;180,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	872	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1202	72.4	0	.	n	.	0	A197.	DEL	197	197	A	660	660	A	202	A	193	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	197.3	1	SNP	p	D86N	0	.	.	256	258	GAC	625	627	GAC	261;261;263	G;A;C	241;240;245	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	197.3	1	SNP	p	R87I	0	.	.	259	261	CGT	628	630	CGT	263;264;263	C;G;T	246;244;242	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	197.3	1	SNP	p	S87R	1	.	.	259	261	CGT	628	630	CGT	263;264;263	C;G;T	246;244;242	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	197.3	1	SNP	p	R87W	0	.	.	259	261	CGT	628	630	CGT	263;264;263	C;G;T	246;244;242	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	197.3	1	SNP	p	S88P	0	.	.	262	264	TCC	631	633	TCC	262;261;263	T;C;C	242;241;244	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3898	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2682	144.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1561	1563	GGC	200;196;194	G;G;C	185;180;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1281	1283	GCC	250;251;252	G;C,T;C	226;226,1;227	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1284	1286	ATG	252;252;256	A;T;G	229;226;234	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1296	1298	ACC	246;246;247	A;C;C	223;226;228	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1296	1298	ACC	246;246;247	A;C;C	223;226;228	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1797	1799	ACC	221;219;221	A;C;C	199;206;205	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1851	1853	GCG	227;232;231	G;C;G	213;217;217	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1851	1853	GCG	227;232;231	G;C;G	213;217;217	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1974	1976	GGT	160;156;156	G;G;T,C	148;143;142,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1983	1985	AGC	153;149;146	A,G;G;C	138,1;137;133	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3982	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2419	163.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2001	2003	CCG	139;140;140	C,CGG;C,G;G	103,1;104,2;107	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6062	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2979	202.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1562	1564	CCG	201;202;203	C;C;G	175;181;182	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2260	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1791	125.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	148	C	134	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	628	630	GAA	272;270;272	G;A;A	255;255;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	916	918	GAT	265;265;268	G;A;T	241;242;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1039	1041	TCA	263;264;267	T;C;A	245;248;255	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	D212_N213insNT	INS	634	634	G	1151	1151	A	246	A	238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1174	1176	GTC	235;235;233	G,A;T,C;C	222,1;224,1;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1186	1188	TCT	241;240;241	T;C,T;T	236;234,1;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	1	SNP	p	G120K	1	.	.	358	360	AAG	874	876	AAG	252;246;247	A;A;G	240;235;236	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	1	SNP	p	A121D	1	.	.	361	363	GAC	877	879	GAC	247;246;250	G;A;C	235;235;237	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3288	porB1b	1047	1047	98.77	porB1b.l6.c4.ctg.1	1765	184.3	1	SNP	p	D121N	0	.	.	361	363	GAC	877	879	GAC	247;246;250	G;A;C	235;235;237	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12858	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4942	259.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1360	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	966	138.7	1	SNP	p	V57M	1	.	.	169	171	ATG	461	463	ATG	304;304;305	A;T;G	279;277;275	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
